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Functional neuroanatomy of nociception and pain
Abstract
Pain is a complex sensory state based on the integration of a variety of 
nociceptive inputs processed centrally through many parallel and overlapping 
neural systems. The traditional anatomical concept implies that nociceptive 
information is dominantly used to generate and regulate perception of pain 
through one major sensory pathway. It becomes recognized that experiencing 
the affective component of the pain is at least as important as perception. 
Also, nociceptive information is strongly influencing brain centers for regu-
lating homeostasis. So, understanding neuroanatomical organization of 
central processing of nociceptive information is of great clinical importance. 
There is an attempt to simplify this complex set of interacting networks to a 
core set of brain regions or a generalizable pain signature. Herewith we wish 
to give a short overview of recent advances by presenting principles about 
neuroanatomical organization for processing various aspects of nociceptive 
inputs.
GenerAl neuroAnAtomicAl principles in 
nociceptive processinG
Pain is the most distinctive of all the sensory modalities (1) but can be simply defined as the subjective experience associated with actual or 
potential tissue damage (2–5). It serves an important protective function 
and warns to avoid or treat injury. The perception of pain is subjective 
and can vary greatly among individuals. Moreover, in the same individ-
ual an identical sensory stimulus can elicit quite distinct conscious re-
sponses under different conditions. This includes also psychological con-
ditions, such as fear or anxiety that can significantly influence the 
experience of pain. So, more than most sensory modalities, the perception 
of pain is influenced by emotional state and environmental contingency, 
is dependent on experience, and varies so markedly from person to person 
(6–16), and consequently remains notoriously difficult to treat .
Noxious stimuli, including tissue injury, activate nociceptors (from 
the Latin, noceo = to injure, hurt) which are present in peripheral struc-
tures and transmit information to the CNS: from the body to the spinal 
cord dorsal grey column, from the skin of the head to the spinal and 
principal trigeminal nucleus, and from the neck mucosa to the lower 
2/3rd of solitary tract nucleus (17–19). To generate perception of pain 
the information should continue ultimately to the cerebral cortex. From 
anatomical point of view it should be noted that nociception refers to 
the process through which information about peripheral stimuli is trans-
mitted by primary afferent nociceptors to the spinal cord, brainstem, 
thalamus, and subcortical structures. For the experience of pain, activ-
ity of thalamocortical networks that process the information conveyed 
by pathways of nociception is needed (20–26) (Figure 1).
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Pain sensation is not the direct expression of a sensory 
event. It has strong urgent and primitive quality with af-
fective and emotional components (7; 26–32), and has 
also influence on homeostatic functioning (33; 34). By 
classical neuroanatomical description pain processing is 
dominantly related to spino- and trigemino-thalamic 
pathway (17–19), still this pathway is evolutionary newest 
in conducing nociceptive information (35). Pain is actu-
ally a complex sensory state that reflects the integration 
of many sensory signals and is the product of elaborate 
brain processing. Particularly complex processing is need-
ed for experiencing the affective component of the pain 
and for the influencing on homeostasis. Numerous paral-
lel and overlapping neural systems processing nociceptive 
information allow such a complex impact on the brain 
functioning (22; 36–40). Among the ascending pathways 
arising from the spinal cord and its trigeminal homologue 
are the spinothalamic and spinoreticulothalamic tracts, 
as well as the spinoparabrachial-amygdala pathway, which 
provides more direct access to limbic emotional circuits 
in the brain. There is an attempt to simplify this complex 
set of interacting networks to a core set of brain regions 
or a generalizable pain signature. Such approaches iden-
tify the following areas as key to experiencing pain: the 
thalamus, the posterior and anterior insula, the postcen-
tral gyrus, the anterior cingulate cortex, and the periaq-
ueductal gray matter. Functional specificity of this com-
plex pattern is still unresolved.
Altogether, understanding neuroanatomical organi-
zation of central processing of nociceptive information 
is of great clinical importance (41-45). Herewith we wish 
to give a short overview of recent advances in under-
Figure 1. Structures containing neurons processing nociception and pain.
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standing neuroanatomical organization for various as-
pects of nociceptive processing and to relate neural struc-
tures and pathways to various submodalities of 
nociceptive processing.
moleculAr AnAtomy of 
peripherAl nociceptive 
processinG
Nociceptors, structures that respond selectively to 
stimuli that can damage tissue are widely distributed in 
the skin and deep tissues and include thermal, mechani-
cal, and polymodal sensory receptors (46-49). They re-
spond directly to mechanical and thermal stimuli, and 
indirectly to other stimuli by means of chemicals released 
from cells in the traumatized tissue. Fourth class, so called 
“silent” nociceptors are found in the viscera. The nocicep-
tors are free nerve endings of the peripheral axonal 
branches originating from primary sensory neurons. The 
cell bodies of nociceptors that convey information from 
the body are located in the dorsal root ganglia. Trigeminal 
ganglia and superior ganglia of glossopharyngeus and 
vagus contain somatic neurons processing nociceptive 
stimuli from skin, cranial periost and dura, the mucosa 
of eye, nasal sinuses, oral and nasal cavity and possibly 
part of tympanic tube and cavity. For the rest of tym-
panic tube and cavity, and the whole mucosa of pharynx 
and larynx primary visceral neurons are located in the 
inferior ganglia of glossopharyngeus and vagus (17). The 
central branches of these primary neurons enter the cen-
tral nervous system through spinal or cranial nerves where 
they make synaptic connections with a complex array of 
neurons that play different roles in nociceptive processing 
and pain. Trigeminal, glossopharyngeal and vagal nerve 
convey somatic information into the trigeminal nuclei, 
and visceral information into the nucleus of the solitary 
tract. The spinal nerve conveys nociceptive information 
from the body and viscera and terminates on neurons in 
the dorsal horn of the spinal cord. Afferent fibers innervat-
ing viscera project to the CNS through autonomic nerves; 
some spinal afferents travel along hypogastric, lumbar 
colonic and splanchnic nerves to terminate in thoraco-
lumbar regions as part of sympathetic innervation, while 
vagal and pelvic afferents respectively terminate in the 
brainstem and lumbosacral cord and contribute to para-
sympathetic innervation. Thoracic branches of vagus also 
contain afferent fibers, but the nature to conduct pain 
information from thoracic and abdominal viscera is not 
clarified.
Based on the myelination of their afferent fibers noci-
ceptors in the skin, muscle, joints, and visceral receptors 
fall into two broad classes (2; 50-52). The first class are 
small diameter, thin myelinated Ad fibers that innervate 
nociceptors producing short-latency pain described as 
sharp and pricking. The majority are mechanoreceptors 
because they are activated by sharp objects that penetrate, 
squeeze, or pinch the skin. In addition, many of these Ad 
fibers also respond to noxious heat that can burn the skin. 
Electrophysiological studies have subdivided Ad nocicep-
tors into two main classes: type I and type II. Type I re-
spond to both mechanical and chemical stimuli, but have 
relatively high heat thresholds (>50°C). These fibers medi-
ate the first pain provoked by pinprick and other intense 
mechanical stimuli. Type II Ad nociceptors have a much 
lower heat threshold, but a very high mechanical thresh-
old; these fibers mediate the “first” acute pain response to 
noxious heat. The second class are nociceptors innervated 
by small diameter, unmyelinated C fibers producing dif-
fusely distributed and poorly tolerated dull, burning pain. 
Under this heterogeneous class the most common type 
are polymodal nociceptors activated by a variety of nox-
ious mechanical, thermal, and chemical stimuli, such as 
Table 1





sharp cutting pain mechanical nociceptors Ad fibers
dull burning pain polymodal nociceptors C fibers 
deep aching pain from viscera visceral nociceptors Ad, C fibers
burning pain thermal-mechanical (hot) Ad fibers
freezing pain thermal-mechanical (cold) C fibers
Non-Nociceptive Pain
(neurophatic or symphatetic)
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pinch or puncture, noxious heat and cold, and irritant 
chemicals applied to the skin. Electrical stimulation of 
these fibers in humans evokes prolonged sensations of 
burning pain. Of particular interest are the heat respon-
sive, but mechanically insensitive unmyelinated afferents 
(so-called silent nociceptors) that develop sensitivity when 
the chemical milieu of inflammation alters their proper-
ties (53).
Visceral fibers can serve sensory function and evoke 
conscious sensations and also afferent function and regu-
late autonomic flow. Visceral sensory afferents are almost 
exclusively thinly myelinated Ad-fibres and unmyelinated 
C-fibres. However, the distinction between nociceptive 
afferents and non-nociceptive afferents in the viscera is 
not clear. Nociceptors in the viscera that produce sensa-
tions of intense pain are activated by distension or swell-
ing. Silent nociceptors found in the viscera are not nor-
mally activated by noxious stimulation. However, after 
tissue insult these nociceptors “wake up” in response to 
endogenous chemical mediators associated with tissue 
injury. Silent nociceptors are typically associated with in-
creased spontaneous activity and responsiveness to nox-
ious and even innocuous stimulus intensities. Their acti-
vation is thought to contribute to the development of 
secondary hyperalgesia and central sensitization, two 
prominent pain syndromes.
The membrane of the nociceptor contains protein 
complexes forming receptors and channels that transduce 
thermal, mechanical, or chemical energy of noxious stim-
uli into electrical impulses, which are propagated along 
the peripheral and central axon of the nociceptor into the 
central nervous system. Biochemical and molecular anal-
ysis of the nociceptor has identified multiple nociceptor 
subclasses, each expressing a distinctive repertoire of 
membrane ion channels, receptors and intracellular sig-
naling proteins that are attractive targets for the develop-
ment of drugs for therapeutic intervention in clinical pain 
conditions (54-56). This includes voltage-gated sodium, 
potassium and calcium channels, leak channels, and li-
gand-gated channels such as acid-sensing ion channels 
and transient receptor potential (TRP) channels (57). The 
role of transient receptor potential ion channels in ther-
mal sensation was originally discovered by analyses of 
natural substances such as capsaicin and menthol that 
produce burning or cooling sensations when applied to 
the skin or injected subcutaneously. Capsaicin, the active 
ingredient in chili peppers, has been used extensively to 
activate nociceptive afferents that mediate sensations of 
burning pain (58). The varieties of TRP channels in no-
ciceptors underlie the perception of a wide range of tem-
peratures from extreme cold to intense heat. Some classes 
of TRP receptors are activated by cold temperatures and 
inactivated by warming (TRPM8 and TRPA1receptors) 
while some types of TRP receptors are activated by warm 
or hot temperatures and inactivated by cooling (TRPV3, 
TRPV1, TRPV2  and TRPV4 receptors) (59-61). A key 
role in the perception of pain in humans plays the voltage-
gated sodium channel NaV1.7, found exclusively in the 
periphery and its mutation can lead to the inability to 
experience pain (62). An ionotropic purinergic receptor, 
PTX3, that is activated by adenosine triphosphate (ATP) 
released from peripheral cells after tissue damage is also 
expressed by nociceptors (63-65). In addition, nociceptors 
express members of the Mas-related G protein-coupled 
receptor (Mrg) family, which are activated by peptide li-
gands. They serve to sensitize nociceptors to other chem-
icals released in their local environment (66-68). 
Neuroanatomical and molecular characterization of 
nociceptors demonstrated their heterogeneity; various 
functionally and molecularly heterogeneous classes of 
nociceptors associate with specific function in the detec-
tion of distinct pain submodalities (69).
mechAnisms modulAtinG 
nociceptive processinG
The proper function of the nociceptive system enables 
and enforces protective behavioral responses such as with-
drawal or avoidance to acutely painful stimuli. In case of 
an injury the vulnerability of the affected tissue is going 
to increase (70-75). The nociceptive system adapts to this 
enhanced vulnerability by locally lowering the nocicep-
tive thresholds and by facilitation of nocifensive respons-
es. The behavioral correlates of these adaptations are al-
lodynia (condition in which non-noxious events are 
perceived as noxious) and hyperalgesia (mildly noxious 
events are perceived as highly noxious). However, hyper-
algesia and allodynia may persist long after the initial 
cause for pain or may occur due to dysfunction of parts 
of the peripheral or central nervous system and become 
maladaptive rather than protective.
Two types of hyperalgesia, primary and secondary, are 
associated with different mechanisms. Primary hyperal-
gesia develops at the site of tissue injury associated with 
an increased sensitivity of the peripheral nerve fibers in-
volved in pain. Secondary hyperalgesia develops in unin-
jured tissue surrounding the site of injury. This form of 
hyperalgesia is not caused by sensitization of nociceptive 
nerve endings but due to changes in the excitability of 
neurons in the central nervous system, including the spi-
nal cord and supra-spinal sites in the brain. Recent evi-
dence suggests, however, that altered processing in the 
central nervous system is equally important in the induc-
tion of primary hyperalgesia (70).
Numerous mediators in the peripheral and central ner-
vous systems contribute to the processes of sensitization. 
The sensitization of nociceptors is triggered by chemical 
mediators released from distinct cell types that accumu-
late at the site of tissue injury and act together to decrease 
the threshold of nociceptor activation, such as histamine, 
anandamide, acetylcholine, serotonin, norepinephrine, 
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prostaglandin, bradykinin, substance P and calcitonin 
gene-related peptide. Central sensitization is a consider-
ably more complicated process that can result from in-
creased release of excitatory neurotransmitter (e.g., gluta-
mate, substance P) and/or enhanced synaptic efficacy. 
These changes relate to several cellular mechanisms (a) 
presynaptic changes, (b) postsynaptic changes, (c) inter-
neuron changes, (d) changes in descending modulation, 
and (e) immune/microglial mechanisms (76; 77).
The understanding of pain mechanisms and pain con-
trol has focused on the properties of primary afferent and 
dorsal horn nociceptive neurons and ascending pathways. 
However, there is an active regulation of sensory transmis-
sion at the level of the dorsal horn by descending projec-
tions arising from a number of brain sites (78-89). De-
scending control plays a critical role in determining the 
experience of pain and can be facilitatory as well as in-
hibitory. The balance between inhibition and facilitation 
is dynamic, and can be altered in different behavioral, 
emotional and pathological states. For example, intense 
stress and fear are associated with decreased responsive-
ness to noxious stimuli that reflects a shift towards de-
scending inhibition. By contrast, inflammation and nerve 
injury, sickness, and chronic opioid administration are 
associated with hyperalgesia that in part reflects a shift 
towards descending facilitation. There is much evidence 
to suggest that descending facilitation of spinal nocicep-
tion is a major contributor to central sensitization and the 
development of secondary hyperalgesia.
Descending control arises from a number of supraspi-
nal sites, including the midline periaqueductal gray-ros-
tral ventromedial medulla (PAG-RVM) system, and the 
more lateral and caudal dorsal reticular nucleus (DRt) and 
ventrolateral medulla (VLM). Serotonergic neurons set-
tled in the raphe nuclei and neorepinephrine neurons 
settled in the locus coerlues play the major role in de-
scending control. Inhibitory control from the PAG-RVM 
system preferentially suppresses nociceptive inputs medi-
ated by C-fibers, preserving sensory-discriminative infor-
mation conveyed by more rapidly conducting A-fibers. 
Analysis of the circuitry within the RVM reveals that the 
neural basis for bidirectional control from the midline 
system is two populations of neurons, ON-cells and OFF-
cells that are differentially recruited by higher structures 
important in fear, illness and psychological stress to en-
hance or inhibit pain.
functionAl neuroAnAtomy of 
centrAl nociceptive processinG
The pain-related circuitry extends over both the cogni-
tive and the emotional-motivational domains of the brain. 
It includes the spinothalamic component of the antero-
lateral fasciculus, the trigeminothalamic tract and path-
ways that connect the spinal cord and the sensory nuclei 
of the trigeminal nerve with the brain stem, the hypo-
thalamus and the basal forebrain (17).
The central branches of primary neurons enter the cen-
tral nervous system and make synaptic connections with 
a complex array of neurons. This triggers the release of 
neurotransmitters such as glutamate and substance P, 
which activate second-order neurons that project to the 
brain. The spinal gray dorsal horn-column (and its equiv-
alent, the caudal part of trigeminal nerve nucleus) consti-
tutes one of the main relay stations for primary afferents 
of the dorsal roots. 
Besides nociceptive-specific neurons, the spinal dorsal 
horn (especially deeper laminae) also contains wide dy-
namic range (WDR) neurons that respond to both in-
nocuous and noxious stimuli. After entering the spinal 
cord (through lateral division of peripheral nerve) small 
myelinated Ad and unmyelinated C fibers terminate in 
the dorsal horn. The spinal gray matter in the dorsal horn 
is divided into six layers of cells (90-93). Nociception spe-
cific neurons in the lamina I respond selectively to nox-
ious inputs from Ad or C fibers and project to higher brain 
structures. Other classes of lamina I responed to both 
innocuous and noxious mechanical stimulation and thus 
are termed wide-dynamic-range neurons. Neurons in 
laminae II and III are interneurons that receive inputs 
from Ad and C fibers, and make excitatory or inhibitory 
connections to neurons in lamina I, IV, and V that project 
to higher brain centers. Wide-dynamic-range neurons in 
lamina V typically respond to a wide variety of noxious 
stimuli and project to the brain stem and thalamus. Neu-
rons in lamina V also receive input from nociceptors in 
visceral tissues. 
Many neurons located in laminae VII and VIII, build-
ing the intermediate grey and deep part of ventral gray 
column, have complex response properties to noxious 
stimuli because the inputs from nociceptors to these neu-
rons are conveyed through many intervening synapses. 
Whereas most dorsal horn neurons receive unilateral in-
put, neurons in lamina VII often respond to stimulation 
of both side of the body and therefore contribute to the 
diffuse quality of many pain conditions. Visceral C fibers 
terminate ipsilaterally in laminae I, II, V, and X and also 
in lamina V and X of the contralateral gray matter. 
Finally, fibers from lamina I and the nucleus of the 
solitary tract convey information about impending and 
actual tissue damage, and a wide range of visceral stim-
uli; the responses of neurons in lamina V correlate close-
ly with reports of pain intensity, while the lamina VII 
plays a significant role in emotional responses to sensory 
stimuli.
Five major ascending pathways contribute to the cen-
tral processing of nociceptive information: the spinotha-
lamic, spinoreticular, spinomesencephalic, cervicotha-
lamic, and spinohypothalamic tracts.
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From neurons in laminae I, V, and VII, the main tar-
gets of the small-diameter fibers with sensory information 
destined for conscious perception, originates the spino-
thalamic tract that is the principal pathway transmitting 
noxious, thermal, and visceral information to the thala-
mus and cerebral cortex (94). The axons of most neurons 
in lamina I cross the midline, just ventral to the central 
canal, and ascend in the contralateral lateral spinotha-
lamic tract located in the lateral funiculus. Axons of 
lamina V neurons cross the spinal cord and ascend in the 
contralateral ventral spinothalamic tract. Axons from the 
caudal part of spinal trigeminal nucleus form tractus tri-
geminothalamicus lateralis that crosses the midline and 
joins the spinothalamic tract. As a result of the decussa-
tion of spinothalamic fibers in the spinal cord, noxious 
information from each dermatome is transmitted contra-
laterally in the anterolateral column. The importance in 
pain processing through the sphinothalamic tract is dem-
onstrated by experimental and clinical evidence. Electri-
cal stimulation is sufficient to elicit the sensation of pain 
and anterolateral cordotomy results in a marked reduction 
in pain sensation on the side of the body contralateral to 
that of the lesion. As mentioned, information carried by 
small-diameter sensory fibers also reaches the cerebral 
cortex through several polysynaptic routes other than the 
spinothalamic tract (38-40; 95). Although many of these 
pathways originate from neurons in lamina I and V, they 
arise from a different group of neurons and project to 
brain stem nuclei which in turn project to the thalamus 
and to other sites, such as the hypothalamus and amyg-
dala. Neurons that project to sites other than the thala-
mus are involved in homeostatic control, by regulating 
endocrine release and autonomic activity. The spinore-
ticular tract ascends in the anterolateral quadrant of the 
spinal cord and terminates in both the reticular formation 
and the thalamus. It contains the axons of projection neu-
rons in laminae VII and VIII and do not cross the mid-
line. The spinomesencephalic (spinoparabrachial) tract 
projects in the anterolateral quadrant of the spinal cord 
to the mesencephalic reticular formation and periaque-
ductal gray matter. It contains the axons of projection 
neurons in laminae I and V. Information transmitted 
along this tract are thought to contribute to the affective 
component of pain. They also course through the dorsal 
part of the lateral funiculus and project to the parabra-
chial nucleus. Neurons of the parabrachial nucleus project 
to the amygdala, a key nucleus of the limbic system that 
regulates emotional states.  The spinohypothalamic tract 
projects to hypothalamic nuclei that serve as autonomic 
control centers involved in the regulation of the neuroen-
docrine and cardiovascular responses that accompany 
pain syndromes. It contains the axons of neurons in lam-
inae I, V, and VIII. The cervicothalamic tract runs in the 
lateral white matter of the upper two cervical segments of 
the spinal cord and contains the axons of neurons of the 
lateral cervical nucleus, which receives input from neu-
rons in laminae III and IV of the dorsal horn. Most axo-
ns in the cervicothalamic tract cross the midline and as-
cend in the medial lemniscus of the brain stem, 
terminating in midbrain nuclei and in the ventroposte-
rior nuclei of the thalamus. The signals from nociceptors 
in the pelvic and abdominal viscera are relayed through 
other neurons in laminae III and IV of the sacral and 
midthoracic spinal cord which project axon through the 
most medial part of the white dorsal column terminating 
in the gracile nucleus. 
The thalamus represents a key integrative structure for 
the processing of pain and thus contains several relay nu-
clei that participate in the central processing of nocicep-
tive information. 
The lateral nuclear group comprises the ventroposte-
rior medial nucleus, the ventroposterior lateral nucleus, 
and the dorsal posterior nucleus that receive inputs from 
nociception-specific and wide-dynamic-range neurons in 
laminae I and V of the dorsal horn through the spinotha-
lamic tract. The lateral thalamus is thought to be con-
cerned with the processing of information about the pre-
cise location of an injury, information usually conveyed 
to consciousness as acute pain. The medial nuclear group 
of the thalamus comprises the central lateral nucleus of 
the thalamus and the intralaminar complex and receives 
major input from neurons in laminae VII and VIII of the 
spinal cord. Many neurons in the medial thalamus re-
spond optimally to noxious stimuli and project widely to 
the basal ganglia and different cortical areas. The pathway 
to the medial thalamus was the first spinothalamic projec-
tion evident in the evolution of mammals and is therefore 
known as the paleospinothalamic tract. It is also some-
times referred to as the spinoreticulothalamic tract be-
cause it includes indirect connections through the reticu-
lar formation of the brain stem. The projection from the 
lateral thalamus to the ventroposterior nuclei is most de-
veloped in primates, and is termed the neospinothalamic 
tract.
Regarding cortical processing it should be emphasized 
that pain is a complex perception that involves many ar-
eas. Spatial, temporal and intensity aspects of pain percep-
tion are processed in the primary and secondary somato-
sensory cortex (S1 and S2, respectively). The anterior 
cingulate cortex and insular cortex are involved in pro-
cessing emotional states associated with pain, while the 
dorsal posterior insula contributes to the autonomic com-
ponent of pain responses. Moreover, the prefrontal cortex 
with corresponding mediodorsal thalamic nucleus and 
premotor areas in connection with cerebellum are also 
commonly activated by painful stimulation.
functionAl neuroAnAtomy of pAin 
submodAlities
The sense of pain includes a response to external events 
that damage or harm the body and therefore belongs to 
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extroceptive sensation. Although the sense of the function 
of the major organ systems of the body and its internal 
state (interoception) do not become conscious sensation, 
abnormal function in major organ systems resulting from 
disease or trauma can evoke conscious sensations of pain.
When pain is experienced it can be acute, persistent or 
chronic (76). Persistent pain characterizes many clinical 
conditions and is usually the major reason why patients 
seek medical attention. In contrast, chronic pain does not 
serve a useful biological function; it only makes patients 
miserable (7; 31; 32; 96-101). Persistent pain can be sub-
divided into two broad classes, nociceptive and neuro-
pathic (Table 1). Nociceptive pains result from the direct 
activation of nociceptors in the skin or soft tissue in re-
sponse to tissue injury and usually arise from accompany-
ing inflammation. Sprains and strains produce mild forms 
of nociceptive pain, whereas arthritis or a tumor that in-
vades soft tissue produces a much more severe nociceptive 
pain. Pain may also result from injury to sensory fibers or 
from damage to the central nervous system. These types 
of pain are designated as non-nociceptive or neuropathic 
pain (77; 102-105). Neuropathic pains include the syn-
dromes of reflex sympathetic dystrophy, also called com-
plex regional pain syndrome, and post-herpetic neuralgia, 
the severe pain experienced by patients after a bout of 
shingles. Other neuropathic pains include phantom limb 
pain (106-109), the pain that occurs after limb amputa-
tion. In some instances pain can even occur without a 
peripheral stimulus, a phenomenon termed anesthesia 
dolorosa. This syndrome can be triggered following at-
tempts to block chronic pain, for example after therapeu-
tic transection of sensory afferent fibers in the dorsal roots.
Sharp, pricking pain is produced by nociceptors in-
nervated by Ad fibers and activated by sharp objects that 
penetrate, squeeze, or pinch the skin (mechanical noci-
ceptors). Dull, burning pain that is diffusely localized and 
poorly tolerated is produced by nociceptors innervated by 
C fiber (polymodal nociceptors). When a stone hits your 
elbow, you initially feel a sharp, fast, momentary pain, 
called first pain and conveyed by Ad fibers followed by a 
more prolonged aching and sometimes burning pain 
(“second pain”) which is transmitted by the C fibers.
There is a clear demarcation between the perception of 
innocuous warmth and noxious heat. This enables us to 
avoid temperatures capable of causing tissue damage. If 
skin temperature changes slowly, we are unaware of 
changes in the range 31° to 36°C. Below 31°C the sensa-
tion progresses from cool to cold and finally, beginning 
at 10° to 15°C, to pain. Above 36°C the sensation pro-
gresses from warm to hot and then, beginning at 45°C, 
to pain. The freezing pain is produced by cold nociceptors 
innervated by C fibers, while the burning pain is pro-
duced by heat nociceptors innervated by Ad fibers. Ther-
mal stimuli activate specific classes of TRP ion channels 
in the membrane (60). Two classes of TRP receptors are 
activated by cold temperatures and inactivated by warm-
ing; TRPM8 receptors respond to temperatures below 
25°C (such temperatures are perceived as cool or cold), 
while TRPA1 receptors have thresholds below 17°C (this 
range is described as cold or frigid). Four types of TRP 
receptors are activated by warm or hot temperatures and 
inactivated by cooling; TRPV3 receptors are expressed in 
warm type fibers and they respond to warming of the skin 
above 35°C (generate sensations ranging from warm to 
hot). TRPV1 and TRPV2 receptors are expressed in heat 
nociceptors and respond to temperatures exceeding 45°C 
(mediate sensations of burning pain). TRPV4 receptors 
are activated by temperatures above 27°C and respond to 
normal skin temperatures.
Visceral pain (deep aching pain) is sensations of in-
tense, diffuse, often poorly localized pain. Diffuse nature 
and difficulty in locating visceral pain is due to a low 
density of visceral sensory innervation and extensive spi-
nal distribution of visceral C fibers. Visceral pain is often 
associated with marked autonomic phenomena: nausea, 
gastrointestinal disturbances, pallor, profuse sweating, 
and changes in blood pressure, heart rate and body tem-
perature. In addition, visceral pain frequently produces 
referred pain, a condition in which pain from injury to a 
visceral tissue is perceived as originating from a region of 
the body surface. Referred pain is sharper, better localized 
and less likely to be accompanied by autonomic signs, and 
therefore difficult to differentiate from pain of somatic 
origin. Convergence of visceral and somatic afferent fibers 
may account for referred pain phenomenon. Nociceptive 
afferent fibers from the viscera and fibers from specific 
areas of the skin converge on the same projection neurons 
in the dorsal horn (lamina V neurons). Thus, a signal from 
this neuron does not inform higher brain centers about 
the source of the input and the brain incorrectly attributes 
the pain to the skin. Another anatomical explanation for 
instances of referred pain is that the axons of nociceptive 
sensory neurons branch in the periphery, innervating 
both skin and visceral targets (110; 111). 
There is one unpleasant sensation showing consider-
able apparent overlap in the neuronal cells and circuits 
that transmit pain, the itch. It is characterized by a strong 
innate urge to scratch and is confined to the skin, the 
ocular conjunctiva, and the mucosa. Itch was considered 
to be related to pain, because painful stimuli such as 
scratching inhibits while some analgesics (e.g. opioids) 
can cause itch. In addition, some itch-causing compounds 
(pruritogens) induce inflammatory pain, and under cer-
tain circumstances some pain-causing compounds (algo-
gens) induce itch. Finally, there is a broad overlap between 
relevant mediator systems in pain and itch. Parallels be-
tween pain and itch processing are even more evident in 
the pattern of central sensitization. Touch- and pin prick-
induced pain (allodynia and punctate hyperalgesia) cor-
relate to touch- and pin prick induced itch (alloknesis and 
punctate hyperknesis). However, recent discoveries about 
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molecular and cellular basis of itch cover diverse aspects 
of itch sensation, from the identification of new receptors 
to the characterization of spinal cord itch circuits. These 
studies demonstrate that itch sensory signals are clearly 
demarcated from input of other somatosensory modalities 
(pain, touch, temperature) that is achieved by the expres-
sion of dedicated receptors and transmitters in a select 
population of sensory neurons which detect pruritogens. 
Also, itch specificity is maintained in a spinal cord circuit 
by the utilization of specific neurotransmitters and cog-
nate receptors to convey input along a distinct cellular 
pathway (112-116).
recent advances in molecular and 
anatomical processing of pain: clinical 
implications 
Impressive insights into the molecular mechanisms of 
peripheral pain transduction has been recently developed 
opening the way for more effective pain therapies. Hu-
man genetics and molecular biology have revealed spe-
cific channels expressed selectively by nociceptive sensory 
neurons, such as TRP and Na channels, what has led to 
the development of many small-molecule channel an-
tagonists some of which may prove to be effective as selec-
tive peripheral analgesics. The use of transcutaneous and 
dorsal-column electrical stimulation in the control of cer-
tain types of peripheral pain was encouraged by the find-
ing that the balance of activity in small- and large-diam-
eter sensory fibers modulates the perception of pain. Also, 
an observation that stimulation of specific sites in the 
brain stem produces deep analgesia has encouraged efforts 
to control pain by activating endogenous modulatory sys-
tems. In certain clinical conditions intrathecal and epi-
dural administration of opiates induces a potent analgesia. 
However, understanding of the organization of central 
pain circuits under normal and pathological conditions 
remains relatively incomplete and thereby for most central 
pain syndromes there are still no effective pain therapies. 
It is expected that the future progress in pain therapy will 
depend on the research finding about brain circuits that 
transmit nociceptive signals (2; 117-120).
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